Water-soluble phenolics from Phoenix dactylifera fruits as potential reno-protective agent against cisplatin-induced toxicity: pre- and post-treatment strategies

No Thumbnail Available
Authors
Adewale, Omowumi Oyeronke
Oyelola, Roseline Fadera
Adetuyi, Oluwatosin
Adebisi, Oluwaseun Abraham
Adekomi, Damilare Adedayo
Oladele, Johnson Olaleye
Advisors
Issue Date
2024
Type
Article
Keywords
Cisplatin , Nephroprotective , Nephrotoxicity , Phoenix dactylifera , Water-soluble phenolics
Research Projects
Organizational Units
Journal Issue
Citation
Adewale, O.O., Oyelola, R.F., Adetuyi, O.A., Adebisi, O.A., Adekomi, D.A., Oladele, J.O. Water-soluble phenolics from Phoenix dactylifera fruits as potential reno-protective agent against cisplatin-induced toxicity: pre- and post treatment strategies. (2024). Drug and Chemical Toxicology. DOI: 10.1080/01480545.2024.2329762
Abstract

Nephrotoxicity is the major side effect of cisplatin, an effective platinum-based chemotherapeutic drug that is applicable in the treatment of several solid-tissue cancers. Studies have indicated that certain water-soluble phenolics offer renal protection. Thus, this study investigates the role of pre and post-treatment of rats with water-soluble phenolics from Phoenix dactylifera (PdP) against nephrotoxicity induced by cisplatin. Rats were either orally pretreated or post-treated with 200 mg/kg body weight of PdP before or after exposure to a single therapeutic dose of cisplatin (5 mg/kg body weight) for 7 successive days intraperitoneally. The protective effects of PdP against Cisplatin-induced nephrotoxicity was based on the evaluation of various biochemical and redox biomarkers, together with histopathological examination of kidney tissues. The composition, structural features, and antioxidative influence of PdP were determined based on chromatographic, spectroscopic, and in vitro antioxidative models. Cisplatin single exposure led to a substantial increase in the tested renal function biomarkers (uric acid, creatinine, and urea levels), associated with an increase in malondialdehyde indicating lipid peroxidation and a significant decline (p < 0.05) in reduced glutathione (GSH) levels in the renal tissue when compared with the control group. A marked decline exists in the kidney antioxidant enzymes (catalase, SOD, and GPx). Nevertheless, treatment with PdP significantly suppressed the heightened renal function markers, lipid peroxidation, and oxidative stress. Spectroscopic analysis revealed significant medicinal phenolics, and in vitro tests demonstrated antioxidative properties. Taken together, results from this study indicate that pre- and/or post-treatment strategies of PdP could serve therapeutic purposes in cisplatin-induced renal damage. © 2024 Informa UK Limited, trading as Taylor & Francis Group.

Table of Contents
Description
Publisher
Taylor and Francis Ltd.
Journal
Drug and Chemical Toxicology
Book Title
Series
PubMed ID
ISSN
0148-0545
EISSN